International Inc. in a bid to acquire Allergan Inc., the maker of Botox, for $56
billion.
The proposed deal made headlines because of its whopping valuation as well as the
unique team on the buy side. Valeant partnered with activist investor Bill Ackman
and his hedge fund management firm, Pershing Square C...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In